Matrix Remodeling in Pulmonary Fibrosis and Emphysema.

PubWeight™: 0.80‹?›

🔗 View Article (PMID 26741177)

Published in Am J Respir Cell Mol Biol on June 01, 2016

Authors

Tejaswini Kulkarni1,2, Philip O'Reilly1,2, Veena B Antony1,2, Amit Gaggar1,2,3, Victor J Thannickal1,2,3

Author Affiliations

1: 1 Department of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine, University of Alabama at Birmingham, Birmingham, Alabama.
2: 2 Program in Protease and Matrix Biology Center, Birmingham, Alabama; and.
3: 3 Birmingham VA Medical Center, Birmingham, Alabama.

Articles cited by this

(truncated to the top 100)

Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell (2003) 25.94

An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med (2011) 22.39

Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol (2002) 14.80

Matrix metalloproteinases: regulators of the tumor microenvironment. Cell (2010) 12.90

The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell (1999) 11.59

Making sense of latent TGFbeta activation. J Cell Sci (2003) 8.90

Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat Med (2005) 8.49

Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol (1993) 8.36

Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science (1997) 8.19

TGFβ signalling in context. Nat Rev Mol Cell Biol (2012) 8.08

Chronic obstructive pulmonary disease in non-smokers. Lancet (2009) 6.41

Bone marrow-derived progenitor cells in pulmonary fibrosis. J Clin Invest (2004) 5.97

Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-beta1: potential role in idiopathic pulmonary fibrosis. Am J Pathol (2005) 5.88

Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung. J Clin Invest (1997) 5.77

Myofibroblast contraction activates latent TGF-beta1 from the extracellular matrix. J Cell Biol (2007) 5.60

Fibronectin at a glance. J Cell Sci (2002) 5.51

Idiopathic pulmonary fibrosis. N Engl J Med (2001) 5.49

A novel peptide CXCR ligand derived from extracellular matrix degradation during airway inflammation. Nat Med (2006) 5.05

Negative regulation of transforming growth factor-beta by the proteoglycan decorin. Nature (1990) 4.90

Mechanisms of pulmonary fibrosis. Annu Rev Med (2004) 4.37

Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med (2011) 4.16

Recent developments in myofibroblast biology: paradigms for connective tissue remodeling. Am J Pathol (2012) 4.13

Loss of integrin alpha(v)beta6-mediated TGF-beta activation causes Mmp12-dependent emphysema. Nature (2003) 4.02

Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition. Proc Natl Acad Sci U S A (2011) 3.82

Transient expression of IL-1beta induces acute lung injury and chronic repair leading to pulmonary fibrosis. J Clin Invest (2001) 3.72

The fibronectin domain ED-A is crucial for myofibroblastic phenotype induction by transforming growth factor-beta1. J Cell Biol (1998) 3.65

Hyaluronan in tissue injury and repair. Annu Rev Cell Dev Biol (2007) 3.62

PDGF-A signaling is a critical event in lung alveolar myofibroblast development and alveogenesis. Cell (1996) 3.60

Circulating fibrocytes: collagen-secreting cells of the peripheral blood. Int J Biochem Cell Biol (2004) 3.34

Reversal of persistent fibrosis in aging by targeting Nox4-Nrf2 redox imbalance. Sci Transl Med (2014) 3.23

An immunohistochemical study of architectural remodeling and connective tissue synthesis in pulmonary fibrosis. Am Rev Respir Dis (1989) 3.12

Elastin fragments drive disease progression in a murine model of emphysema. J Clin Invest (2006) 3.11

Smad3 null mice develop airspace enlargement and are resistant to TGF-beta-mediated pulmonary fibrosis. J Immunol (2004) 2.95

Increased production and immunohistochemical localization of transforming growth factor-beta in idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol (1991) 2.89

Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. The role of HA size and CD44. J Clin Invest (1996) 2.86

Smad3 deficiency attenuates bleomycin-induced pulmonary fibrosis in mice. Am J Physiol Lung Cell Mol Physiol (2002) 2.83

Remodelling the extracellular matrix in development and disease. Nat Rev Mol Cell Biol (2014) 2.74

Neutrophil elastase contributes to cigarette smoke-induced emphysema in mice. Am J Pathol (2003) 2.66

A novel proteolytic cascade generates an extracellular matrix-derived chemoattractant in chronic neutrophilic inflammation. J Immunol (2008) 2.58

The serpin alpha1-proteinase inhibitor is a critical substrate for gelatinase B/MMP-9 in vivo. Cell (2000) 2.49

Platelet-derived growth factor in idiopathic pulmonary fibrosis. J Clin Invest (1990) 2.29

Overview of the matrisome--an inventory of extracellular matrix constituents and functions. Cold Spring Harb Perspect Biol (2012) 2.26

Combinatorial activation of FAK and AKT by transforming growth factor-beta1 confers an anoikis-resistant phenotype to myofibroblasts. Cell Signal (2006) 2.22

Roles of mechanical forces and collagen failure in the development of elastase-induced emphysema. Am J Respir Crit Care Med (2001) 2.20

Regulated splicing of the fibronectin EDA exon is essential for proper skin wound healing and normal lifespan. J Cell Biol (2003) 2.16

Pulmonary fibrosis: patterns and perpetrators. J Clin Invest (2012) 2.05

Molecular pathogenesis of emphysema. J Clin Invest (2008) 2.03

Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol (2002) 2.00

Evolving concepts of apoptosis in idiopathic pulmonary fibrosis. Proc Am Thorac Soc (2006) 1.98

Pathological integrin signaling enhances proliferation of primary lung fibroblasts from patients with idiopathic pulmonary fibrosis. J Exp Med (2008) 1.93

An essential role for fibronectin extra type III domain A in pulmonary fibrosis. Am J Respir Crit Care Med (2007) 1.91

Mechanical interactions between collagen and proteoglycans: implications for the stability of lung tissue. J Appl Physiol (1985) (2004) 1.85

Inhibition of mechanosensitive signaling in myofibroblasts ameliorates experimental pulmonary fibrosis. J Clin Invest (2013) 1.81

Proteoglycans: from structural compounds to signaling molecules. Cell Tissue Res (2009) 1.80

Cigarette smoke extract induces oxidative stress and apoptosis in human lung fibroblasts. Am J Physiol Lung Cell Mol Physiol (2003) 1.68

Matrix stiffness-induced myofibroblast differentiation is mediated by intrinsic mechanotransduction. Am J Respir Cell Mol Biol (2012) 1.67

Prostaglandin E(2) inhibits collagen expression and proliferation in patient-derived normal lung fibroblasts via E prostanoid 2 receptor and cAMP signaling. Am J Physiol Lung Cell Mol Physiol (2006) 1.66

Transforming growth factor beta regulates the levels of different fibronectin isoforms in normal human cultured fibroblasts. FEBS Lett (1988) 1.61

Proteoglycans decorin and biglycan differentially modulate TGF-beta-mediated fibrotic responses in the lung. Am J Physiol Lung Cell Mol Physiol (2001) 1.60

Prostaglandin E(2) inhibits fibroblast chemotaxis. Am J Physiol Lung Cell Mol Physiol (2001) 1.55

Fibrotic extracellular matrix activates a profibrotic positive feedback loop. J Clin Invest (2014) 1.54

Increase in macrophage elastase (MMP-12) in lungs from patients with chronic obstructive pulmonary disease. Inflamm Res (2005) 1.50

Lung fibroblast repair functions in patients with chronic obstructive pulmonary disease are altered by multiple mechanisms. Am J Respir Crit Care Med (2008) 1.50

Serum lysyl oxidase-like 2 levels and idiopathic pulmonary fibrosis disease progression. Eur Respir J (2013) 1.47

Expression and localization of tumor necrosis factor-alpha and its mRNA in idiopathic pulmonary fibrosis. Am J Pathol (1993) 1.42

Transforming growth factor-beta1 genotype and susceptibility to chronic obstructive pulmonary disease. Thorax (2004) 1.39

The stumbling block in lung repair of emphysema: elastic fiber assembly. Proc Am Thorac Soc (2006) 1.28

Transforming growth factor-beta regulates the splicing pattern of fibronectin messenger RNA precursor. FEBS Lett (1990) 1.28

Extracellular matrix biology in the lung. Am J Physiol (1996) 1.27

Thy-1-integrin alphav beta5 interactions inhibit lung fibroblast contraction-induced latent transforming growth factor-beta1 activation and myofibroblast differentiation. J Biol Chem (2010) 1.25

Type II alveolar epithelial cells and interstitial fibroblasts express connective tissue growth factor in IPF. Eur Respir J (2001) 1.25

Activation of elastin transcription by transforming growth factor-beta in human lung fibroblasts. Am J Physiol Lung Cell Mol Physiol (2007) 1.24

Induction and regulation of macrophage metalloelastase by hyaluronan fragments in mouse macrophages. J Immunol (1999) 1.24

Hyaluronan in respiratory injury and repair. Am J Respir Crit Care Med (2003) 1.23

Changes in elastin, elastin binding protein and versican in alveoli in chronic obstructive pulmonary disease. Respir Res (2008) 1.22

Proteoglycan deposition in pulmonary fibrosis. Am J Respir Crit Care Med (1996) 1.16

Diverse functions of matrix metalloproteinases during fibrosis. Dis Model Mech (2014) 1.16

Cigarette smoke-induced lung emphysema in mice is associated with prolyl endopeptidase, an enzyme involved in collagen breakdown. Am J Physiol Lung Cell Mol Physiol (2010) 1.15

Fibrosis: ultimate and proximate causes. J Clin Invest (2014) 1.15

Control of alternative splicing in immune responses: many regulators, many predictions, much still to learn. Immunol Rev (2013) 1.14

Altered fibroblast proteoglycan production in COPD. Respir Res (2010) 1.14

EDA-containing cellular fibronectin induces fibroblast differentiation through binding to alpha4beta7 integrin receptor and MAPK/Erk 1/2-dependent signaling. FASEB J (2010) 1.11

A new lock-step mechanism of matrix remodelling based on subcellular contractile events. J Cell Sci (2010) 1.10

Neutrophils contain prolyl endopeptidase and generate the chemotactic peptide, PGP, from collagen. J Neuroimmunol (2009) 1.09

Regulation of fibroblast migration by tenascin-C. Biochem Soc Trans (2007) 1.08

Proteinases and oxidants as targets in the treatment of chronic obstructive pulmonary disease. Proc Am Thorac Soc (2005) 1.08

β-arrestin deficiency protects against pulmonary fibrosis in mice and prevents fibroblast invasion of extracellular matrix. Sci Transl Med (2011) 1.06

The pathogenesis of COPD and IPF: distinct horns of the same devil? Respir Res (2012) 1.06

Tenascin-C deficiency attenuates TGF-ß-mediated fibrosis following murine lung injury. Am J Physiol Lung Cell Mol Physiol (2010) 1.03

Proteoglycan changes in the extracellular matrix of lung tissue from patients with pulmonary emphysema. Mod Pathol (1999) 1.03

Different modulation of decorin production by lung fibroblasts from patients with mild and severe emphysema. COPD (2005) 1.02

Enhanced deposition of low-molecular-weight hyaluronan in lungs of cigarette smoke-exposed mice. Am J Respir Cell Mol Biol (2009) 1.00

Extracellular matrix composition in COPD. Eur Respir J (2012) 0.98

Alterations in large and small proteoglycans in bleomycin-induced pulmonary fibrosis in rats. Am J Respir Crit Care Med (2000) 0.98

Extracellular matrix proteins: a positive feedback loop in lung fibrosis? Matrix Biol (2013) 0.96

Matrix biology of idiopathic pulmonary fibrosis: a workshop report of the national heart, lung, and blood institute. Am J Pathol (2014) 0.94

Fibronectin extra domain-A promotes hepatic stellate cell motility but not differentiation into myofibroblasts. Gastroenterology (2011) 0.93

Elastase-released epidermal growth factor recruits epidermal growth factor receptor and extracellular signal-regulated kinases to down-regulate tropoelastin mRNA in lung fibroblasts. J Biol Chem (2002) 0.92

Low α(2)β(1) integrin function enhances the proliferation of fibroblasts from patients with idiopathic pulmonary fibrosis by activation of the β-catenin pathway. Am J Pathol (2012) 0.92

Exposures and idiopathic lung disease. Semin Respir Crit Care Med (2009) 0.91